Gastric sleeve surgery can eliminate overweight in 92 percent of patients, according to a study conducted by the European Medical Obesity Institute, presented on the occasion of the celebration of World Obesity Day, on Wednesday.
To carry out the research, 36 men and 112 women, between 25 and 55 years of age, with “significant” obesity and who had undergone a stomach reduction operation with gastric sleeve, were analyzed over two years. In particular, all began the treatment with a high initial weight, 128 kilos on average for men.
With this treatment, most of the overweight is usually lost during the first six months, at a stable rate where the average weight loss is 7 kilos per month, decreasing the figure with 1.5 kilos in each subsequent semester. Once the goal is achieved, we continue with a balanced diet and training plan to maintain weight and establish a new healthy lifestyle.
On the other hand, the study has also evaluated the risk of cardiovascular disease, hypertension and type II diabetes, measured through the visceral fat factor that marks an interval index from 0 to 40, being from factor 11 when it begins to trigger the risk to the heart and the dangers of the metabolic syndrome.
Now, in addition to promoting weight loss, reducing diabetes and improving hypertension, the gastric sleeve produces a series of endocrine effects that are beneficial for health since, for example, it regulates glucose metabolism, insulin secretion and the function of the pancreas; increases the secretion of growth hormone and slows gastric emptying; and it reduces both the appetite and the feeling of hunger and is a great advance in the fight against severe obesity.